Logo-bi
Bioimpacts. 2024;14(2): 29955. doi: 10.34172/bi.2023.29955
PMID: 38505677        PMCID: PMC10945300

Original Article

Benchmarking different docking protocols for predicting the binding poses of ligands complexed with cyclooxygenase enzymes and screening chemical libraries

Sara Shamsian 1,2 ORCID, Babak Sokouti 3, Siavoush Dastmalchi 2,3,4 * ORCID

Cited by CrossRef: 1


1- Fu H, Mo X, Ivanov A. Decoding the functional impact of the cancer genome through protein–protein interactions. Nat Rev Cancer. 2025; [Crossref]
2- Li K, Lauschke V, Zhou Y. Molecular docking to investigate HLA-associated idiosyncratic drug reactions. Drug Metabolism Reviews. 2025;:1 [Crossref]
3- De Jesús-González L, León-Juárez M, Lira-Hernández F, Rivas-Santiago B, Velázquez-Cervantes M, Méndez-Delgado I, Macías-Guerrero D, Hernández-Castillo J, Hernández-Rodríguez X, Calderón-Sandate D, Mata-Martínez W, Reyes-Ruíz J, Osuna-Ramos J, García-Herrera A. Advances and Challenges in Antiviral Development for Respiratory Viruses. Pathogens. 2024;14(1):20 [Crossref]
4- Cordero A, Gonzales A. Using Multiscale Molecular Modeling to Analyze Possible NS2b-NS3 Protease Inhibitors from Philippine Medicinal Plants. CIMB. 2024;46(7):7592 [Crossref]
5- Son A, Park J, Kim W, Yoon Y, Lee S, Ji J, Kim H. Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy. Toxics. 2024;12(11):822 [Crossref]


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge